Breaking News English

Scientists from Bristol University have found a anotherchallengedonationgoodlaboratorymanymethodolderpatientsphaseprocessproductrarereportersslowsuitablesustainablyteamtechnologyway to mass produce blood that is anotherchallengedonationgoodlaboratorymanymethodolderpatientsphaseprocessproductrarereportersslowsuitablesustainablyteamtechnologyway enough for hospital anotherchallengedonationgoodlaboratorymanymethodolderpatientsphaseprocessproductrarereportersslowsuitablesustainablyteamtechnologyway. For anotherchallengedonationgoodlaboratorymanymethodolderpatientsphaseprocessproductrarereportersslowsuitablesustainablyteamtechnologyway years, they could produce blood in a anotherchallengedonationgoodlaboratorymanymethodolderpatientsphaseprocessproductrarereportersslowsuitablesustainablyteamtechnologyway. However, the anotherchallengedonationgoodlaboratorymanymethodolderpatientsphaseprocessproductrarereportersslowsuitablesustainablyteamtechnologyway to do that was very anotherchallengedonationgoodlaboratorymanymethodolderpatientsphaseprocessproductrarereportersslowsuitablesustainablyteamtechnologyway and they could not make a lot of blood. The new anotherchallengedonationgoodlaboratorymanymethodolderpatientsphaseprocessproductrarereportersslowsuitablesustainablyteamtechnologyway means scientists can make an "unlimited supply" of blood. Researcher Dr Jan Frayne said anotherchallengedonationgoodlaboratorymanymethodolderpatientsphaseprocessproductrarereportersslowsuitablesustainablyteamtechnologyway ways of producing red blood cells used stem cells that could only produce a limited amount of blood. She added: "We have [shown] a [workable] way to anotherchallengedonationgoodlaboratorymanymethodolderpatientsphaseprocessproductrarereportersslowsuitablesustainablyteamtechnologyway manufacture red cells."

Professor David Anstee, anotherchallengedonationgoodlaboratorymanymethodolderpatientsphaseprocessproductrarereportersslowsuitablesustainablyteamtechnologyway researcher, told reporters his anotherchallengedonationgoodlaboratorymanymethodolderpatientsphaseprocessproductrarereportersslowsuitablesustainablyteamtechnologyway now needs the anotherchallengedonationgoodlaboratorymanymethodolderpatientsphaseprocessproductrarereportersslowsuitablesustainablyteamtechnologyway to make blood on a large scale – to mass produce it. He said that would be a anotherchallengedonationgoodlaboratorymanymethodolderpatientsphaseprocessproductrarereportersslowsuitablesustainablyteamtechnologyway. He added: "The next anotherchallengedonationgoodlaboratorymanymethodolderpatientsphaseprocessproductrarereportersslowsuitablesustainablyteamtechnologyway of our work is to look at methods of [producing more]." He told anotherchallengedonationgoodlaboratorymanymethodolderpatientsphaseprocessproductrarereportersslowsuitablesustainablyteamtechnologyway that at first, they would produce only rare types of blood. He said these are difficult to find with traditional blood anotherchallengedonationgoodlaboratorymanymethodolderpatientsphaseprocessproductrarereportersslowsuitablesustainablyteamtechnologyway. He said: "The first…use of [our] red cell anotherchallengedonationgoodlaboratorymanymethodolderpatientsphaseprocessproductrarereportersslowsuitablesustainablyteamtechnologyway is likely to be for patients with anotherchallengedonationgoodlaboratorymanymethodolderpatientsphaseprocessproductrarereportersslowsuitablesustainablyteamtechnologyway blood groups, because anotherchallengedonationgoodlaboratorymanymethodolderpatientsphaseprocessproductrarereportersslowsuitablesustainablyteamtechnologyway…red blood cell donations can be difficult to source."